Orbimed Advisors LLC Insider Trades
EntityDirector at BlossomHill Therapeutics, Inc. and 2 other companies. 3 significant open-market trades reported on SEC Form 4 in the last 180 days.
$59.9M
Bought
$0
Sold
3 / 0
Buys / Sells
3
Companies
Companies
Reported Trades
Open-market transactions only (code P and S), outside any 10b5-1 plan, dated by the day the filing reached EDGAR. Each row links to the filing.
Other Insiders at These Companies
Everyone else who reported a significant open-market trade at the same companies in the last 180 days. Several buyers inside one week is cluster buying.
- Carl L. GordonDirector at BLSM1 buy, $10.0M
- OrbiMed Capital GP Viii LLCDirector at BLSM1 buy, $10.0M
- Marc L. Andreessen10% owner at BRVE1 buy, $19.8M
- Benjamin A. Horowitz10% owner at BRVE1 buy, $19.8M
- Ah Bio Fund Iv, L.P.10% owner at BRVE1 buy, $19.8M
- Ah Equity Partners Bio Iv, L.L.C.10% owner at BRVE1 buy, $19.8M
- Erez ChimovitsDirector at BRVE1 buy, $34.9M
- OrbiMed Capital GP Ix LLCDirector at BRVE1 buy, $34.9M
- OrbiMed Genesis GP LLCDirector at BRVE1 buy, $34.9M
- John P. SchmidDirector at BLSM1 buy, $96K
- Bihua ChenDirector at BLSM1 buy, $5.0M
- Cormorant Asset Management, LP10% owner at BLSM1 buy, $5.0M
How to Read This Page
These are the trades an insider chose to make with their own money, not grants, option exercises or tax withholding. A purchase is the stronger signal (why buys carry more information than sales), and an insider who buys is locked out of selling for six months by the short-swing rule. Several insiders buying at the same company in the same week is cluster buying, the pattern the research literature rates highest. The window here is 180 days; the full filing history lives on EDGAR.
Get this insider's next buy the minute it files
InsiderWatch reads every Form 4 as it reaches EDGAR, keeps the open-market buys that matter, and sends them by email and Telegram.
Try free for 7 daysEvery call scored in public, misses included.